Why over 5 billion people still lack access to life-saving medical oxygen

The Lancet Global Health Commission highlights severe inequities in medical oxygen access, urging systemic reforms to ensure universal availability and affordability.

Cybin Expands Clinical Team to Support CYB003 Phase 3 Program | Psychedelic Invest

Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation

October 1, 2024

SYD-4228 by Byondis for Follicular Lymphoma: Likelihood of Approval

SYD-4228 is under clinical development by Byondis and currently in Phase I for Follicular Lymphoma.

January 9, 2024

Visceral fat found to contribute to Alzheimer’s disease development

Researchers have linked a specific type of body fat to the abnormal proteins in the brain that are hallmarks of Alzheimer’s disease up to 20

December 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.